Searchable abstracts of presentations at key conferences in endocrinology

ea0015p58 | Clinical practice/governance and case reports | SFEBES2008

An audit of the management of primary hyperparathyroidism

Mahawish L , Peacey SR

We undertook a retrospective audit of patients with primary hyperparathyroidism. Patients were identified from the Bradford Endocrine Database.About 101 patients were identified. 13 were incorrectly labelled and excluded. Case records of 88 patients; median age 64 (range 17–87) years, 69 F:19 M, were examined. At diagnosis median corrected calcium was 2.72 (range 2.45–3.69) mmol/l, median PTH 14 (range 3–182) pmol/l and mean 24 h urine cal...

ea0028p248 | Pituitary | SFEBES2012

‘Isolated acquired secondary hypogonadism’ in men referred to an adult endocrine clinic

Kandasamy Narayanan , Baxter Mark , Skittrall Jordan , Annamalai Anand Kumar , Antoun Nagui , Simpson Helen , Halsall David , Gurnell Mark

Background: Acquired male secondary hypogonadism is a relatively common cause of referral to the endocrine clinic. However, the extent to which further investigation is required, and the indications for a trial of testosterone therapy, remain unclear. Aim To review the clinical/biochemical/radiological findings in men presenting with this condition.Methods: We performed a retrospective case analysis of 41 consecutive patients referred to our clinic over ...

ea0062wd2 | Workshop D: Disorders of the adrenal gland | EU2019

Congenital adrenal hyperplasia with testicular adrenal rest tumors

Zia-Ul-Hussnain Hafiz Muhammad , Sherlock Mark , Thompson Chris

A 34 year old male diagnosed with congenital adrenal hyperplasia (21 hydroxylase deficiency, salt wasting variety) shortly after birth. Initial presentation was poor feeding with hypoglycemia, pigmented scrotum with elevated 17-OH progesterone. He had a right orchidopexy at age 9 for undescended testis. He was admitted multiple times with adrenal crises during his childhood. He went through puberty and achieved height of 177 cm which is 75th centile. His sister also has CAH. H...

ea0013p341 | Thyroid | SFEBES2007

The relationship between serum TSH levels and blood pressure in a population sample with normal thyroid function

Razvi Salman , French Joyce , Weaver Jolanta , Vanderpump Mark , Pearce Simon

Background: There is evidence to suggest an association between hypothyroidism (overt and subclinical) and cardiovascular disease. It is unclear whether the set-point of the thyroid axis, within the normal range, may be related to vascular risk.Methods: We have reanalysed the data from the original Whickham study to assess BP in the entire cohort and its relationship to serum TSH within the reference range (0.3–6.0 mIU/L). Multivariate stepwise line...

ea0011p577 | Neuroendocrinology and behaviour | ECE2006

Dietary supplements for stress and obesity co-morbidities reduction

Dimitrov D , Koeva L

The diet of patients exposed to stress had been shown to be low in fibre, low in fruit and vegetables, low in vitamins C and E, and beta-carotene, high in sugar, and high in saturated fat. The implications of these findings are two-fold: the diet associated with stress is similar to those in patients with features of the Metabolic syndrome (Met-S – visceral obesity, diabetes, hyperlipidemia, hypertension).Aim: The aim of the present study was to ass...

ea0010p95 | Thyroid | SFE2005

Thyroid dysfunction in HIV

Qureshi A , Panahloo A , Seal L

A 54 yr old man presented with a six-month history of palpitations, sweating and weight loss. He had a past history of hypertension, type II diabetes, asthma and was HIV-1 seropositive since 14 yrs and was taking potent anti-retroviral therapy: Nevirapine 200 mg bd; Kaletra 3 capsules bd; and didanosine ec 400 mg od.Investigations confirmed Graves thyrotoxicosis (fT4 72.1 pmol/l; TSH <0.01 mU/l; and TSH receptor antibody positive). He was initially t...

ea0028oc3.7 | Obesity, thyroid and Addison's disease | SFEBES2012

Subclinical hypothyroidism is associated with fatigue and impaired functional status in males in the Whickham 20-year follow up cohort

Madathil Asgar , Razvi Salman , Vanderpump Mark , Pearce Simon , Weaver Jolanta

Introduction: The association between fatigue, functional status and subclinical hypothyroidism (SCH) remains unclear. The available data is not consistent, and this is likely to be due to selection bias in studies recruiting patients from clinic rather than unselected community populations. Only population surveys looking at prevalence of fatigue and functional status in SCH are likely to provide the answer.Objective and Methodology: We compared the pre...

ea0070aep755 | Pituitary and Neuroendocrinology | ECE2020

An analysis of incidence and characteristics of cushing’s syndrome in malta: A population based study

Giordano Imbroll Miriam , Giovanna Abela Alexia , Vassallo Josanne , Gruppetta Mark

Aim: There are few reports discussing incidence and characteristics of the whole group of Cushing’s syndrome patients in the literature. The aim was to establish the incidence of endogenous Cushing’s syndrome with in-depth analysis of their various subtypes in a well-defined population.Methods: Retrospective cross-sectional analysis of Cushing’s syndrome patients diagnosed between 2008 and 2017. A thorough search for patients was carrie...

ea0028p41 | Clinical practice/governance and case reports | SFEBES2012

Low prevalence of pituitary pathology in men presenting with isolated hypogonadotrophic hypogonadism

Gibb Fraser , Strachan Mark , Zammitt Nicola , Walker Brian

Background: Male hypogonadotrophic hypogonadism is an increasingly common cause of referral to endocrine clinics. Subnormal testosterone levels are frequently observed in obesity, type 2 diabetes mellitus and in the elderly. Endocrine Society guidelines suggest stratification of investigations based on the degree of androgen deficiency, with full pituitary function testing and MRI recommended only in those with serum testosterone levels less than 5.2 nmol/L. However the eviden...

ea0022p607 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Quality of life after multimodality treatment of acromegaly

Farrugia Cecilia , Gruppetta Mark , Calleja Neville , Vassallo Josanne

Aim: To assess the impact of acromegaly on quality of life (QoL) as evaluated by the acromegaly QoL (AcroQoL) questionnaire in Maltese patients with cured, controlled and uncontrolled acromegaly.Design: Cross-sectional survey study.Methods: The AcroQol questionnaire was completed by all patients during their routine outpatient visit. Clinical and hormonal data including GH and IGF1 levels were also taken at the time of survey.<...